Aldrian Denise, Vogel Georg F, Frey Teresa K, Ayyıldız Civan Hasret, Aksu Aysel Ünlüsoy, Avitzur Yaron, Ramos Boluda Ester, Çakır Murat, Demir Arzu Meltem, Deppisch Caroline, Duba Hans-Christoph, Düker Gesche, Gerner Patrick, Hertecant Jozef, Hornová Jarmila, Kathemann Simone, Koeglmeier Jutta, Koutroumpa Arsinoi, Lanzersdorfer Roland, Lev-Tzion Raffi, Lima Rosa, Mansour Sahar, Meissl Manfred, Melek Jan, Miqdady Mohamad, Montoya Jorge Hernan, Posovszky Carsten, Rachman Yelena, Siahanidou Tania, Tabbers Merit, Uhlig Holm H, Ünal Sevim, Wirth Stefan, Ruemmele Frank M, Hess Michael W, Huber Lukas A, Müller Thomas, Sturm Ekkehard, Janecke Andreas R
Department of Pediatrics I, Medical University of Innsbruck, A-6020 Innsbruck, Austria.
Division of Cell Biology, Biocenter, Innsbruck Medical University, A-6020 Innsbruck, Austria.
J Clin Med. 2021 Jan 28;10(3):481. doi: 10.3390/jcm10030481.
Myosin Vb (MYO5B) is a motor protein that facilitates protein trafficking and recycling in polarized cells by RAB11- and RAB8-dependent mechanisms. Biallelic MYO5B mutations are identified in the majority of patients with microvillus inclusion disease (MVID). MVID is an intractable diarrhea of infantile onset with characteristic histopathologic findings that requires life-long parenteral nutrition or intestinal transplantation. A large number of such patients eventually develop cholestatic liver disease. Bi-allelic MYO5B mutations are also identified in a subset of patients with predominant early-onset cholestatic liver disease. We present here the compilation of 114 patients with disease-causing MYO5B genotypes, including 44 novel patients as well as 35 novel MYO5B mutations, and an analysis of MYO5B mutations with regard to functional consequences. Our data support the concept that (1) a complete lack of MYO5B protein or early MYO5B truncation causes predominant intestinal disease (MYO5B-MVID), (2) the expression of full-length mutant MYO5B proteins with residual function causes predominant cholestatic liver disease (MYO5B-PFIC), and (3) the expression of mutant MYO5B proteins without residual function causes both intestinal and hepatic disease (MYO5B-MIXED). Genotype-phenotype data are deposited in the existing open MYO5B database in order to improve disease diagnosis, prognosis, and genetic counseling.
肌球蛋白Vb(MYO5B)是一种驱动蛋白,通过RAB11和RAB8依赖性机制促进极化细胞中的蛋白质运输和循环利用。在大多数微绒毛包涵体病(MVID)患者中发现了双等位基因MYO5B突变。MVID是一种婴儿期起病的顽固性腹泻,具有特征性组织病理学表现,需要终身肠外营养或肠道移植。大量此类患者最终会发展为胆汁淤积性肝病。在一部分主要表现为早发性胆汁淤积性肝病的患者中也发现了双等位基因MYO5B突变。我们在此展示了114例具有致病MYO5B基因型患者的汇总情况,包括44例新患者以及35个新的MYO5B突变,并对MYO5B突变的功能后果进行了分析。我们的数据支持以下概念:(1)完全缺乏MYO5B蛋白或早期MYO5B截短导致主要的肠道疾病(MYO5B-MVID),(2)具有残余功能的全长突变型MYO5B蛋白的表达导致主要的胆汁淤积性肝病(MYO5B-PFIC),(3)没有残余功能的突变型MYO5B蛋白的表达导致肠道和肝脏疾病(MYO5B-MIXED)。基因型-表型数据已存入现有的开放MYO5B数据库,以改善疾病诊断、预后和遗传咨询。